NASDAQ:CSII

Cardiovascular Systems (CSII) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$20.00
$20.00
50-Day Range
$19.87
$20.00
52-Week Range
$12.26
$20.57
Volume
4,300 shs
Average Volume
765,906 shs
Market Capitalization
$843.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Cardiovascular Systems MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.05
Upright™ Environmental Score
News Sentiment
-0.11mentions of Cardiovascular Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.68) to ($0.51) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.23 out of 5 stars

Medical Sector

887th out of 907 stocks

Surgical & Medical Instruments Industry

92nd out of 96 stocks

CSII stock logo

About Cardiovascular Systems Stock (NASDAQ:CSII)

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

CSII Stock News Headlines

$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Cardiovascular Technologist Salary
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
See More Headlines
Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2023
Today
4/25/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Profitability

Net Income
$-36,930,000.00
Pretax Margin
-15.73%

Debt

Sales & Book Value

Annual Sales
$239.84 million
Book Value
$6.12 per share

Miscellaneous

Free Float
40,594,000
Market Cap
$843.96 million
Optionable
Optionable
Beta
0.74

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives


CSII Stock Analysis - Frequently Asked Questions

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company had revenue of $61.45 million for the quarter, compared to the consensus estimate of $63.06 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 15.39% and a negative net margin of 15.79%. Cardiovascular Systems's quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.23) earnings per share.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

This page (NASDAQ:CSII) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners